Ascentage Pharma (Nasdaq: AAPG) (HKEX: 6855) announced today the pricing of its U.S. initial public offering of 7,325,000 American depositary shares ('ADSs”), at a public offering price of $17.25 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback